D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
DELL
DELL INC
DELL
|
+$537M |
| 2 |
TFCF
Twenty-First Century Fox, Inc. Class B
TFCF
|
+$473M |
| 3 |
Meta Platforms (Facebook)
META
|
+$282M |
| 4 |
ONXX
ONYX PHARMACEUTICALS INC
ONXX
|
+$239M |
| 5 |
SPDR S&P 500 ETF Trust
SPY
|
+$234M |
Top Sells
| 1 |
Apple
AAPL
|
+$771M |
| 2 |
Pfizer
PFE
|
+$320M |
| 3 |
BMC
BMC SOFTWARE, INC
BMC
|
+$264M |
| 4 |
Visa
V
|
+$208M |
| 5 |
eBay
EBAY
|
+$160M |
Sector Composition
| 1 | Technology | 12.11% |
| 2 | Consumer Discretionary | 11.57% |
| 3 | Financials | 11.44% |
| 4 | Healthcare | 10.88% |
| 5 | Communication Services | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1551
Cullen/Frost Bankers
CFR
$8.2B
| $1.01M | ﹤0.01% |
+14,252
| New | +$1.01M |
|
1552
Ethan Allen Interiors
ETD
$742M
| $1M | ﹤0.01% |
+36,029
| New | +$1M |
|
|
AEGN
1553
DELISTED
Aegion Corp
AEGN
| $1M | ﹤0.01% |
42,211
+30,368
| +256% | +$721K |
|
1554
Imunon
IMNN
$14.5M
| $997K | ﹤0.01% |
70
-28
| -29% | -$399K |
|
|
ONCT
1555
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
| $995K | ﹤0.01% |
354
-69
| -16% | -$194K |
|
1556
Vista Gold
VGZ
$229M
| $993K | ﹤0.01% |
2,153,677
+2,010,480
| +1,404% | +$927K |
|
|
LGF
1557
DELISTED
Lions Gate Entertainment
LGF
| $993K | ﹤0.01% |
28,342
-177,781
| -86% | -$6.23M |
|
1558
Belden
BDC
$5.21B
| $992K | ﹤0.01% |
15,492
-21,857
| -59% | -$1.4M |
|
1559
Ducommun
DCO
$1.39B
| $989K | ﹤0.01% |
34,499
+11,424
| +50% | +$327K |
|
1560
Insight Enterprises
NSIT
$3.9B
| $983K | ﹤0.01% |
+51,981
| New | +$983K |
|
|
RLD
1561
DELISTED
REALD INC COM STK
RLD
| $982K | ﹤0.01% |
140,342
-99,628
| -42% | -$697K |
|
|
CIR
1562
DELISTED
CIRCOR International, Inc
CIR
| $981K | ﹤0.01% |
+15,779
| New | +$981K |
|
|
ZGNX
1563
DELISTED
Zogenix, Inc.
ZGNX
| $980K | ﹤0.01% |
65,912
+47,034
| +249% | +$699K |
|
1564
Zimmer Biomet
ZBH
$20.4B
| $977K | ﹤0.01% |
12,250
-31,094
| -72% | -$2.48M |
|
1565
Pearson
PSO
$9.15B
| $976K | ﹤0.01% |
+47,986
| New | +$976K |
|
1566
Amicus Therapeutics
FOLD
$2.46B
| $974K | ﹤0.01% |
419,693
+48,832
| +13% | +$113K |
|
1567
Destination XL Group
DXLG
$80.3M
| $970K | ﹤0.01% |
149,955
-22,752
| -13% | -$147K |
|
1568
TAL Education Group
TAL
$6.67B
| $970K | ﹤0.01% |
401,184
+283,644
| +241% | +$686K |
|
1569
Papa John's
PZZA
$1.65B
| $967K | ﹤0.01% |
27,674
+17,480
| +171% | +$611K |
|
|
APFC
1570
DELISTED
AMERICAN PACIFIC CORP
APFC
| $965K | ﹤0.01% |
+17,625
| New | +$965K |
|
1571
Mercer International
MERC
$206M
| $964K | ﹤0.01% |
135,903
-135,721
| -50% | -$963K |
|
|
LTM
1572
DELISTED
LIFE TIME FITNESS INC
LTM
| $960K | ﹤0.01% |
18,656
-37,440
| -67% | -$1.93M |
|
1573
Aaon
AAON
$6.7B
| $957K | ﹤0.01% |
81,083
-68,747
| -46% | -$811K |
|
|
OABC
1574
DELISTED
OMNIAMERICAN BANCORP INC COM STK (TX)
OABC
| $953K | ﹤0.01% |
38,951
+1,503
| +4% | +$36.8K |
|
1575
Hyster-Yale Materials Handling
HY
$634M
| $951K | ﹤0.01% |
10,610
-4,500
| -30% | -$403K |
|